Keyword: EPM

  • EHM Death Leads to Restrictions at Suffolk

    Following the recent death of one horse stabled at Suffolk Downs from equine herpes myelitis, no horses are being allowed to leave the track, though no official quarantine has been imposed.

  • Two More Horses Dead After Receiving Compound

    The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.

  • Trade Zone: EPM Update

    Few equine conditions cause as much consternation as equine protozoal myeloencephalitis (EPM).

  • HealthWatch: Update on EPM

    EPM remains a rare cause of neurologic disease in horses -- less than 0.5% of horses are diagnosed with EPM annually in the United States. However, if you do the math, 0.5% of all the horses residing in the United States still amounts to several thousand horses diagnosed with EPM each year.

  • Princess Rooney won the inaugural Breeders' Cup Distaff (gr. I)

    Champion Princess Rooney Dead

    Eclipse Award winner Princess Rooney was euthanized at Gentry Brothers Farm near Lexington Oct. 7 due to complications of equine protozoal myeloencephalitis (EPM). She was 28.

  • Dr. James Rooney of Gluck Center Dead

    Dr. James Rooney, the first director of the University of Kentucky's Maxwell H. Gluck Equine Research Center in Lexington, died Sept. 5.

  • Princess Rooney Diagnosed With EPM

    Eclipse Award winner Princess Rooney has been diagnosed with equine protozoal myeloencephalitis and is being treated at Gentry Brothers Farm near Lexington.

  • Horses Entered, But Trainers Holding Their Breath

    Maryland horsemen, in anticipation of the equine herpesvirus quarantine at Pimlico Race Course being lifted, entered 14 horses for the Feb. 8 card at Laurel Park. But some uneasiness remains given the volatile nature of the virus.

  • The Golden Age of Horse Health

    The American Association of Equine Practitioners is celebrating its golden anniversary in 2004, and will hold its 50th annual convention in Denver, Colo., Dec. 4-8. The AAEP was founded in December 1954, in Louisville, Ky., by 11 charter members and now boasts approximately 8,000 members in 57 countries. Based on past conference attendance averages, some 2,700 veterinarians, veterinary students, and technicians will be there, while guests and exhibitors in the trade show that accompanies the conference will bring the grand total to about 5,500.

  • New EPM Treatment Approved

    The U.S. Food and Drug Administration (FDA) Nov. 19 approved Navigator for treating equine protozoal myeloencephalitis (EPM). This drug has been under development for more than six years.

  • Preakness runner-up Magic Weisner, being treated at New Bolton Center.

    Magic Weisner Continues to Improve

    Magic Weisner, the Preakness and Haskell Invititational runner-up, continues to show improvement from treatments he is receiving at the University of Pennsylvania's New Bolton Center. The 3-year-old is being treated with anti-inflammatory medications for the signs of encephalitis.

  • Dr. William Saville.

    Major Breakthrough Made in EPM Research

    Researchers at the U.S. Department of Agriculture and Ohio State University have made a major breakthrough in equine protozoal myeloencephalitis (EPM), finding that the raccoon can serve as an intermediate host for Sarcocystis neurona, the single-celled protozoan parasite that causes the neurological disease.

  • Breakthrough Made on EPM Research

    The most recent <i>Journal of Parasitology</i> contained an article that opens the door for battling equine protozoal myeloencephalitis (EPM). Researchers and others found they could use the common domestic cat as the experimental intermediate host for the life cycle of the causative protozoal parasite.

  • Conditional License Issued for EPM Vaccine

    The U.S. Department of Agriculture has announced that Fort Dodge Laboratories, Inc., has been issued a conditional license for a vaccine intended to aid in the prevention of equine protozoal myeloencephalitis, more commonly known as EPM.